ISIN No
|
INE987B01026
|
BSE Code / NSE Code
|
524816 / NATCOPHARM
|
Book Value (Rs.)
|
424.71
|
Face Value
|
2.00
|
Bookclosure
|
18/02/2025
|
52Week High
|
1639
|
EPS
|
105.26
|
P/E
|
9.49
|
Market Cap.
|
17885.91 Cr.
|
52Week Low
|
727
|
P/BV / Div Yield (%)
|
2.35 / 0.60
|
Market Lot
|
1.00
|
Security Type
|
Other
|
|
You can view latest Board of Directors and Key Executives of the company.
Board of Directors
Sr.No. | Name | Designation |
1
| Mr. V C Nannapaneni | Chairman & Ind.Director |
2
| Mr. Rajeev Nannapaneni | Director & CEO |
3
| Mr. P S R K Prasad | Director & Exe. VP (Corp. Engg. Services) |
4
| Dr. D Linga Rao | Director & President (Tech. Affairs) |
5
| Dr. Pavan Ganapati Bhat | Director |
6
| Mr. D Vijaya Bhaskar | Independent Director |
7
| Mr. A D M Chavali | Independent Director |
8
| Dr. Kantipudi Suma | Addnl. & Ind.Director |
|
Key Executives
Sr.No. | Name | Designation |
1
| Mr. Lakshminarayana A | Senior Vice President |
2
| Mr. Amresh Kumar Trivedi | Deputy General Manager |
3
| Dr. M Pulla Reddy | Executive Vice President |
4
| Mr. Rajesh Chebiyam | Executive Vice President |
5
| Dr. Ramesh Dandala | Executive Vice President |
6
| Dr. Pratima Jain | Vice President |
7
| Mr. Ramakrishna Sridhar Reddy | Senior Vice President |
8
| Mr. Sunil Kotaru | Senior Vice President |
|